Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Active Control, Parallel Group, Randomized, Double-blind, Phase II Clinical Trial to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops in Patients With Dry Eye Disease

NCT05733624 is registered in ClinicalTrials.gov with SCAI Therapeutics as lead sponsor.

NCT NCT05733624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05733624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Active Control, Parallel Group, Randomized, Double-blind, Phase II Clinical Trial to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops in Patients With Dry Eye Disease
Lead sponsor
SCAI Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
January 5, 2023
Completion date
February 2, 2024
Enrollment
116 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndromes